JORGE ALVARO GONZALEZ Y MARTINEZ
Jorge Gonzalez-Martinez, MD, PhD, FAANS, is a board-certified and world-renowned neurosurgeon subspecializing in epilepsy and functional neurosurgery. He is director of the University of Pittsburgh Department of Neurological Surgery Epilepsy & Movement Disorders Program and is co-director of the distinguished UPMC Epilepsy Center.
Dr. Gonzalez-Martinez is a medical pioneer in novel surgical methods for treating medically refractory seizures such as stereo-electroencephalography, SEEG guided laser ablative procedures, neuromodulatory interventions and robotic guided surgeries, bringing for the first time innovative surgical interventions to the United States and other countries. His particular field of interest and academic drive is related to neuro-electrophysiology, intracranial signal processing and behavioral neuroscience studies. Combined, the clinical and basic science efforts have been guiding his academic and clinical pathway for safer and more efficient methods for treating patients with severe seizures and abnormal movement disorders, promoting the improvement of symptoms, in combination with better functional and quality of life outcomes.
Dr. Gonzalez-Martinez has published more than 180 peer-reviewed articles and book chapters related to epilepsy surgery and methods of brain mapping for patients with medically intractable epilepsy and movement disorders.
He has been a member of the American Society of Stereotactic and Functional Neurosurgery executive committee since 2013, developing high relevant projects and topics related to the field of functional neurosurgery and epilepsy.
RENATO P. MUNHOZ
Professor associado em neurologia da Universidade de Toronto Neurologista Toronto Western Hospital, University Health Network e Mount Sinai Hospital. Co Diretor do Serviço de Neuromodulação e codiretor da Clínica da Ataxia, Toronto Western Hospital Investigador Clinico do Krembil Research Institute, Toronto, Canada.
PATRICIO RIVA POSSE
Dr. Patricio Riva Posse is a dually trained neurologist and psychiatrist, subspecialized in treatment-resistant mood disorders. He is the Medical Director of the Treatment Resistant Depression Clinic in the Department of Psychiatry at Emory University. Dr. Riva Posse is involved daily in the diagnosis, treatment and management of a difficult to treat population, providing clinical services such as medication management, electroconvulsive therapy, repetitive transcranial magnetic stimulation, and off-label ketamine infusions. He is also the director of the Deep Brain Stimulation for Depression program at Emory University. He coordinates the clinical and experimental aspects of the DBS for depression program. Dr. Riva Posse has published on the use of neuroimaging to guide surgical implantation, as well as electrophysiological analyses of DBS patients.
VOLKER A. COENEN
Dr. Coenen has graduated from medical school at the RWTH Aachen, Germany in 1998. In 1999 he joined the residency program in Aachen, Germany. In 2005 he was appointed as consultant neurosurgeon in Aachen, Germany. In 2007 he joined the Functional Neurosurgery program at the University of British Columbia, Vancouver, Canada as a Fellow. In 2008 he was appointed as full professor at the division of Stereotaxy and MR-based OR techniques at Bonn University, Germany. Since 2013 he is appointed as Full Professor and department head of the Department of Stereotactic and Functional Neurosurgery at Freiburg University, Germany.
The main interest of Dr. Coenen's scientific group is the application of the deep brain stimulation (DBS) technology for various indications (Movement disorders, predom. Parkinson’s disease, dystonia, tremor and epilepsies). One of his main focuses is the treatment refractory depression (MD). He researches the application of neuromodulation of the reward system to treat psychiatric diseases. In the laboratory his group works towards the identification of the depression circuitry in the rat and in the human primate in a translational approach. A main focus is the anatomical and functional description of the ventral tegmental area (VTA). His research is geared towards the development of new and more efficacious target regions for DBS using the DTI technology an application that he has pioneered. His current works aims at the development of closed loop neuromodulation systems with neurochemical feedback. Together with the Department of interventional Biological Psychiatry in Freiburg (head: Thomas E. Schläpfer, M.D.) he spearheads the initiative to stimulate the medial forebrain bundle in depression and OCD. Dr. Coenen has published more than 120 peer reviewed articles.